---
figid: PMC6072829__ott-11-4413Fig7
figlink: /pmc/articles/PMC6072829/figure/f7-ott-11-4413/
number: F7
caption: 'Illustration of anticancer effect of Zyflamend against NFκB pathway in UBC
  cells.Abbreviations: UBC, urinary bladder cancer; NFκB, nuclear factor kappaB.'
pmcid: PMC6072829
papertitle: Combination chemotherapy with Zyflamend reduced the acquired resistance
  of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway.
reftext: Yanshi Xue, et al. Onco Targets Ther. 2018;11:4413-4429.
pmc_ranked_result_index: '4966'
pathway_score: 0.9034529
filename: ott-11-4413Fig7.jpg
figtitle: Zyflamend and NFKB pathway
year: '2018'
organisms: Homo sapiens
ndex: e194343f-de8e-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6072829__ott-11-4413Fig7.html
  '@type': Dataset
  description: 'Illustration of anticancer effect of Zyflamend against NFκB pathway
    in UBC cells.Abbreviations: UBC, urinary bladder cancer; NFκB, nuclear factor
    kappaB.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCND1
  - RELA
  - RELB
  - UBC
  - NFKB2
  - REL
  - NFKB1
  - VEGFC
  - MYC
  - VEGFD
  - MMP2
  - MMP9
  - BCL2
  - VEGFB
  - VEGFA
  - PGF
  - Cisplatin
  - Cancer
genes:
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: UBC
  symbol: UBC
  source: hgnc_symbol
  hgnc_symbol: UBC
  entrez: '7316'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: MMP2/9
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: MMP2/9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
chemicals:
- word: Cisplatin
  source: MESH
  identifier: D002945
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6072829__F7
redirect_from: /figures/PMC6072829__F7
figtype: Figure
---
